Xiaofang Guo Selected Research

Xiaofang Guo Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 05/2011
7	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2012
7	Nasopharyngeal Carcinoma 01/2017 - 01/2012
5	Infections 01/2022 - 01/2012
4	Carcinogenesis 06/2020 - 09/2011
3	Hypoxia (Hypoxemia) 06/2020 - 01/2019
3	Adenocarcinoma of Lung 06/2020 - 08/2016
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2017
2	Pre-Eclampsia (Preeclampsia) 12/2023 - 01/2022
2	Inflammation (Inflammations) 12/2023 - 01/2012
2	Malaria 06/2022 - 05/2014
2	Hodgkin Disease (Hodgkin's Disease) 06/2018 - 07/2016
2	Triple Negative Breast Neoplasms 12/2017 - 01/2017
2	Lupus Nephritis 01/2014 - 02/2013
2	Glioma (Gliomas) 12/2011 - 05/2011
1	Rectal Neoplasms (Rectal Cancer) 05/2024
1	Circulating Neoplastic Cells 05/2024
1	Adenomyosis 11/2023
1	Flushing 04/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Genomic Instability 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 09/2022
1	Esophageal Squamous Cell Carcinoma 09/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	COVID-19 01/2022
1	Pregnancy Complications 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Lung Injury 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Endometriosis 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 06/2020
1	Hypoalbuminemia 06/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
7	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2011
6	Messenger RNA (mRNA)IBA 11/2023 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 05/2011
3	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2021
3	Small Interfering RNA (siRNA)IBA 11/2023 - 06/2020
3	EnzymesIBA 01/2021 - 01/2012
3	BerberineIBA 12/2018 - 03/2013
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 08/2016
2	CytokinesIBA 01/2022 - 01/2012
2	CollagenIBA 01/2021 - 05/2020
2	Cadherins (E-Cadherin)IBA 06/2020 - 12/2017
2	Sorafenib (BAY 43-9006)FDA Link 06/2020 - 12/2017
2	VimentinIBA 06/2020 - 12/2017
2	CateninsIBA 06/2020 - 12/2017
2	B7-H1 AntigenIBA 06/2018 - 01/2017
2	Nucleosomes (Nucleosome)IBA 01/2014 - 02/2013
2	Histones (Histone)IBA 01/2014 - 02/2013
2	AutoantibodiesIBA 01/2014 - 02/2013
2	LactoferrinIBA 12/2012 - 01/2012
1	Epithelial Cell Adhesion MoleculeIBA 05/2024
1	LeptinIBA 12/2023
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 11/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2023
1	Carrier Proteins (Binding Protein)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Leukemia Inhibitory FactorIBA 11/2023
1	Heavy MetalsIBA 04/2023
1	ferric chlorideIBA 04/2023
1	MetalsIBA 04/2023
1	Amino Acids FDA Link 01/2023
1	Gefitinib (Iressa)FDA Link 09/2022
1	Lapatinib (GW572016)FDA Link 09/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 09/2022
1	Insulin-Like PeptidesIBA 09/2022
1	InsecticidesIBA 06/2022
1	Therapeutic UsesIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	Interleukin-11 (Interleukin 11)IBA 01/2022
1	SteroidsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Viral RNAIBA 01/2022
1	4-hydroxyestradiolIBA 01/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2021
1	SmokeIBA 01/2021
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2021
1	Propranolol (Inderal)FDA LinkGeneric 01/2021
1	2-hydroxyestradiolIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	tizoxanideIBA 12/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2020
1	Glutamine (L-Glutamine)FDA Link 06/2020
1	CarbonIBA 06/2020
1	AlbuminsIBA 06/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 06/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020

Therapy/Procedure

7	Therapeutics 01/2019 - 05/2011
3	Drug Therapy (Chemotherapy) 05/2020 - 10/2012
2	Microspheres (Microsphere) 07/2023 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2017
2	Radiotherapy 07/2016 - 10/2012
1	Neoadjuvant Therapy 05/2024
1	Critical Care (Surgical Intensive Care) 06/2020